TY - JOUR T1 - <em>Staphylococcus aureus</em> bacteraemia management: where do we stand and where are we going? JF - Evidence Based Medicine JO - Evid Based Med SP - 126 LP - 126 DO - 10.1136/ebmed-2014-110122 VL - 20 IS - 4 AU - Pamela A Moise AU - George Sakoulas Y1 - 2015/08/01 UR - http://ebm.bmj.com/content/20/4/126.abstract N2 - Commentary on: Holland TL, Arnold C, Fowler VG Jr.. Clinical management of Staphylococcus aureus bacteraemia: a review. JAMA 2014;312:1330–41.OpenUrlCrossRefPubMedWeb of ScienceStaphylococcus aureus is a common cause of bacteraemia from hospitalised patients in the USA. It is also a very prevalent bacterial pathogen among clinical isolates from outpatients. Despite our technological innovations within and outside of the practice of science and medicine in the past two decades, mortality due to S. aureus bacteremia (SaB) has not changed during this time, remaining at about 20%. The goals of this review were to determine which patients with SaB need transesophageal echocardiography (TEE) and to determine the optimal antibiotic regimen.This largely narrative review by Holland and colleagues provides a thorough literature review on the clinical data on which therapeutic and diagnostic standards in … ER -